VERFYNDA Trademark

Trademark Overview

On Wednesday, May 10, 2017, a trademark application was filed for VERFYNDA with the United States Patent and Trademark Office. The USPTO has given the VERFYNDA trademark a serial number of 87445030. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 4, 2022. This trademark is owned by Purdue Pharma. The VERFYNDA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis

Providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
verfynda

General Information

Serial Number87445030
Word MarkVERFYNDA
Filing DateWednesday, May 10, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 4, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders, mood disorders, oppositional defiance disorder, conduct disorder, learning disabilities, autism spectrum disorder, tic disorders, binge eating and obsessive eating disorders, anxiety disorders, substance abuse disorders, depression, psychosis
Translation of Words in MarkThe wording "VERFYNDA" has no meaning in a foreign language.
Goods and ServicesProviding health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, via a website, the Internet or other global communication networks; providing health information to health care providers about pharmaceutical preparations, including pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 15, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 15, 2017
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePURDUE PHARMA L.P.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901
Party NamePURDUE PHARMA L.P.
Party Type11 - New Owner Before Publication
Legal Entity Type13 - Limited Partnership
AddressSTAMFORD, CT 06901
Party NamePurdue Pharma
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA

Trademark Events

Event DateEvent Description
Tuesday, July 5, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 4, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, October 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2021SOU EXTENSION 5 GRANTED
Thursday, October 21, 2021SOU EXTENSION 5 FILED
Thursday, October 28, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 21, 2021SOU TEAS EXTENSION RECEIVED
Saturday, May 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2021SOU EXTENSION 4 GRANTED
Thursday, May 20, 2021SOU EXTENSION 4 FILED
Thursday, May 20, 2021SOU TEAS EXTENSION RECEIVED
Saturday, November 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2020SOU EXTENSION 3 GRANTED
Thursday, November 19, 2020SOU EXTENSION 3 FILED
Thursday, November 19, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, May 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 11, 2020SOU EXTENSION 2 GRANTED
Monday, May 11, 2020SOU EXTENSION 2 FILED
Monday, May 11, 2020SOU TEAS EXTENSION RECEIVED
Friday, November 29, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 27, 2019SOU EXTENSION 1 GRANTED
Wednesday, November 27, 2019SOU EXTENSION 1 FILED
Wednesday, November 27, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 25, 2019ELECTRONIC RECORD REVIEW COMPLETE
Friday, February 22, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, February 20, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 15, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 15, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 13, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, February 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 15, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 15, 2018INQUIRY TO SUSPENSION E-MAILED
Wednesday, August 15, 2018SUSPENSION INQUIRY WRITTEN
Saturday, August 4, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, July 13, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 13, 2018ASSIGNED TO LIE
Friday, June 29, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Saturday, February 3, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, February 3, 2018LETTER OF SUSPENSION E-MAILED
Saturday, February 3, 2018SUSPENSION LETTER WRITTEN
Tuesday, January 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 5, 2017NON-FINAL ACTION E-MAILED
Saturday, August 5, 2017NON-FINAL ACTION WRITTEN
Friday, August 4, 2017ASSIGNED TO EXAMINER
Wednesday, May 17, 2017TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, May 17, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, May 15, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 13, 2017NEW APPLICATION ENTERED

Related Keywords

verfynda disorders pharmaceutical preparations disorder health nervous system treatment diseases central